Pain
Conference Coverage
Perioperative scripts for migraine abortive drugs linked with fewer pain readmissions
PHILADELPHIA - Migraine patients who underwent any surgery and then received a prescription for a migraine abortive drug had fewer 30-day pain...
Conference Coverage
Opioid use is common among migraineurs who take prescription medication
PHILADELPHIA – Despite recommendations against it, opioid use is common among migraineurs.
Conference Coverage
Maternal migraine is associated with infant colic
PHILADELPHIA – Mothers with migraine are more likely to have babies with colic, a cross-sectional study finds.
Conference Coverage
Migraine comorbidities rise with increased headache days
PHILADELPHIA – As the number of migraine headache days per month rises, the prevalence of comorbidities like insomnia and depression also increase...
From the Journals
Opioid exposure leads to poor perinatal and postnatal outcomes
Data from women at increased risk for opioid abuse show need for long-term support for mothers and children.
Latest News
Medical cannabis laws appear no longer tied to drop in opioid overdose mortality
"Cannabinoids have demonstrated therapeutic benefits, but reducing population-level opioid overdose mortality does not appear to be among them,"...
Latest News
Mindfulness-based stress reduction reduces migraine frequency
SAN ANTONIO – The intervention also led to reductions in anxiety, depression, and stress symptoms and an increase in gray matter volume.
From the Journals
Gabapentinoids associated with suicidal behavior, overdose
Pregabalin is associated with greater risk, compared with gabapentin, and the associations are strongest in patients aged 15-24 years.
From the Journals
Varicella vaccine delivers doubled benefit to children
Varicella vaccine not only protects against chicken pox but also confers effective protection against pediatric zoster.
Feature
Opioid prescriptions declined 33% over 5 years
The number of opioid prescriptions decreased 33% nationally from 2013 to 2018, according to the new report from the American Medical Association...
News from the FDA/CDC
Stewart Tepper: Emgality approval ‘very exciting’
The treatment binds to calcitonin gene-related peptide and is the first therapy to reduce the frequency of episodic cluster headache attacks.